{Reference Type}: Journal Article
{Title}: One-Year Results of Ear Reconstruction with 3D Printed Implants.
{Author}: Kim M;Kim YJ;Kim YS;Roh TS;Lee EJ;Shim JH;Kang EH;Kim MJ;Yun IS;
{Journal}: Yonsei Med J
{Volume}: 65
{Issue}: 8
{Year}: 2024 Aug
{Factor}: 3.052
{DOI}: 10.3349/ymj.2023.0444
{Abstract}: <B>OBJECTIVE: </B>External ear reconstruction has been a challenging subject for plastic surgeons for decades. Popular methods using autologous costal cartilage or polyethylene still have their drawbacks. With the advance of three-dimensional (3D) printing technique, bioscaffold engineering using synthetic polymer draws attention as an alternative. This is a clinical trial of ear reconstruction using 3D printed scaffold, presented with clinical results after 1 year.<BR><B>METHODS: </B>From 2021 to 2022, five adult patients with unilateral microtia underwent two-staged total ear reconstruction using 3D printed implants. For each patient, a patient-specific 3D printed scaffold was designed and produced with polycaprolactone (PCL) based on computed tomography images, using fused deposition modeling. Computed tomography scan was obtained preoperatively, within 2 weeks following the surgery and after 1 year, to compare the volume of the normal side and the reconstructed ear. At 1-year visit, clinical photo was taken for scoring by two surgeons and patients themselves.<BR><B>RESULTS: </B>All five patients had completely healed reconstructed ear at 1-year follow-up. On average, the volume of reconstructed ear was 161.54% of that of the normal side ear. In a range of 0 to 10, objective assessors gave scores 3 to 6, whereas patients gave scores 8 to 10.<BR><B>CONCLUSIONS: </B>External ear reconstruction using 3D printed PCL implant showed durable, safe results reflected by excellent volume restoration and patient satisfaction at 1 year postoperatively. Further clinical follow-up with more cases and refinement of scaffold with advancing bioprinting technique is anticipated. The study's plan and results have been registered with the Clinical Research Information Service (CRIS No. 3-2019-0306) and the Ministry of Food and Drug Safety (MFDS No. 1182).